News Search Results
Jul 07, 2025, 14:54 ET Global Industrial Enzyme Markets: Innovation, Impact, and Growth
Protein Synthesis Research Review: The 2024 Protein Synthesis Research Review highlights the latest breakthroughs in genetic translation, synthetic biology, and drug development. It showcases innovative technologies and research shaping the future of protein engineering and biomedical applications.
More news about: BCC Research LLC
Jun 30, 2025, 07:45 ET ARTAN Bio Partners with Syenex VivoCell Platform for Precision in vivo Delivery of Next-Generation Codon Suppressors for Aging
SyenexSyenex is an open-science biotechnology platform company that enables developers to program cells with precision and scale. Leveraging synthetic biology and a global network of contract development and manufacturing organizations (CDMOs), Syenex provides plug-and-play delivery platforms—spanning
More news about: Syenex
Jun 25, 2025, 02:00 ET Novo Nordisk Foundation and University of Copenhagen announce USD 109 million grant to new Danish research centre to make designed proteins with vast potential
the University of Bristol, UK, where he has pioneered protein design and led initiatives such as BrisSynBio, a Synthetic Biology Research Centre. The Novo Nordisk Foundation has long recognised the great potential of protein design. "De novo protein design
More news about: Novo Nordisk Foundation; University of Copenhagen
Jun 19, 2025, 10:29 ET Biodefense Market Size worth $22.8 billion, Globally, by 2030 with 5% CAGR - Exclusive Study by The Research Insights
security rapidly change today, biodefense market capabilities are being transformed by technological advancements. Technological advances in synthetic biology and genomic surveillance along with rapid diagnostics and
More news about: The Research Insights
Jun 18, 2025, 07:59 ET TAM Center Officially Opens its Doors in Mexico: A New Global Hub for Cancer Diagnosis, Regenerative Medicine, and Translational Science
companies across the U.S., Europe, and Latin America. These pioneers in genomics, synthetic biology, cell therapy, tumor immunology, and multiomic data integration are now part of TAM's next phase. TAM Center is not just treating disease.
More news about: The TAM Center
Jun 17, 2025, 10:45 ET Bioprocessing Equipment Market to Reach USD 162.2 Billion by 2035, Says Meticulous Research®
bioprocessing equipment market is undergoing significant growth, fueled by rapid advancements in biopharmaceuticals, precision medicine, and synthetic biology. With a strong CAGR of 9.2%, the market is seeing increasing demand for advanced manufacturing tools used in producing monoclonal antibodies,
More news about: Meticulous Market Research Pvt. Ltd.
Jun 17, 2025, 09:00 ET AMBASSADOR SIMONE BILES FRONTS THE NEW K18 AIRWASH™ FITNESS CAMPAIGN
salon-exclusive damage repair service that protects, strengthens, and preserves hair health through even extreme salon services. As the leader in synthetic biology for beauty, K18 sets itself apart by addressing hair health from the inside out, rather than relying on surface-level solutions. With over 20
More news about: K18 Biomimetic Hairscience
Jun 12, 2025, 14:00 ET New England Biolabs® Announces Winners of the 2025 Monarch Nucleic Acid Purification Scholarship
nucleic acid purification," says Matthew Norton, Product Marketing Manager for NEB's nucleic acid purification & synthetic biology product lines. "We're honored to highlight their research, and the myriad ways they have contributed to their communities as scientists and educators."
More news about: New England Biolabs, Inc.
Jun 11, 2025, 10:15 ET Dental Soft-tissue Regeneration Market worth $0.53 billion in 2030 with 6.8% CAGR | MarketsandMarkets™
Synthetic Biology Market Get access to the latest updates on
More news about: MarketsandMarkets
Jun 05, 2025, 10:30 ET Oligonucleotide Synthesis Market worth US$24.7 billion by 2030 with 10.8% CAGR | MarketsandMarkets™
in therapeutics & diagnostics. This growth is supported by technological advancements and rising investments in life sciences research and synthetic biology. Additionally, the growing emphasis on precision and personalized medicine contributes to this expansion, creating new opportunities as key players
More news about: MarketsandMarkets
Jun 03, 2025, 10:30 ET MATTERWORKS INC. SECURES SERIES A FUNDING TO ADVANCE MACHINE INTELLIGENCE FOR PREDICTIVE BIOLOGY
specialize in early stage investments at the intersection of biology, big data, and Al, with a focus on therapeutics, bio tools, diagnostics, and synthetic biology platforms.
More news about: Matterworks
Jun 02, 2025, 22:46 ET AmphiStar and Kensing Announce Strategic Partnership to Bring Upcycled Biosurfactants to the North American Personal Care Market
biosurfactants are the result of an IP-backed breakthrough technology featuring an unprecedented combination in the surfactant landscape: advanced synthetic biology, waste processing and continuous biomanufacturing principles.By eliminating reliance on fossil feedstocks and resource-intensive crops,
More news about: Kensing LLC
May 30, 2025, 10:09 ET HH Chemical Launches BIODEX® -- The World's First Fully Integrated Bio-Based Materials Brand Tackling Multi-Industry Challenges Through Innovation
Chemical and the National University of Singapore (NUS), under the SINERGY (Singapore Consortium for Synthetic Biology). Leveraging palm oil byproducts and HH Chemical's proprietary biosynthesis platform, the BIODEX® series was patented and scaled for commercial
More news about: HH CHEMICAL
May 29, 2025, 16:30 ET Amyris Takes Full Ownership of Brazilian Industrial Fermentation Plant and Invests in Completion of Fourth Precision Fermentation Line
Calif., May 29, 2025 /PRNewswire/ -- Amyris, Inc., a vertically integrated synthetic biology company and leading innovator in the field of industrial biotechnology, today announced that it has acquired Ingredion's 31% stake in the RealSweet
More news about: Amyris, Inc.
May 29, 2025, 16:30 ET Amyris and Ingredion Wind Down RealSweet Joint Venture
Ill., May 29, 2025 /PRNewswire/ -- Amyris, Inc., a vertically integrated synthetic biology company and leading innovator in the field of industrial biotechnology, and Ingredion Incorporated (NYSE: INGR), a leading global provider of
More news about: Amyris, Inc.
May 29, 2025, 10:45 ET Precision Fermentation Ingredients Market worth $36.31 billion by 2030- Exclusive Report by MarketsandMarkets™
toward ethical consumption, requirements to lower greenhouse gas emissions related to conventional animal farming, and process advancements in synthetic biology that provide cost-efficient and scalable manufacturing of functional ingredients like proteins,
More news about: MarketsandMarkets
May 21, 2025, 22:38 ET MGI Tech Unveils Next-Generation Automation Portfolio at SLAS Europe 2025 in Germany
advanced robotics, AI integration, and modular platforms, MGI's automation portfolio addresses critical challenges in genomics, drug discovery, synthetic biology, and molecular diagnostics—empowering labs of all sizes to scale research efficiently. PrepALL: Compact, Affordable Automation for Flexible Pipetting
More news about: MGI TECH
May 21, 2025, 16:05 ET Ginkgo Bioworks Announces Appointment of Steven Coen as Chief Financial Officer
business opportunities, including with respect to our solutions and tools offerings, (iv) the risk of downturns in demand for products using synthetic biology, (v) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (vi) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
May 19, 2025, 12:17 ET Persist AI Launches Cloud Lab to Accelerate Pharmaceutical Formulation Development, Raises $12M Series A Funding
development. Prior to founding Persist, Raman was part of the automation team at Zymergen, developing the next generation robotic factory for synthetic biology. Co-founder Christopher Shelner serves as Chief Operating Officer, with significant expertise in automation design,
More news about: Persist AI Formulations
May 13, 2025, 11:00 ET Integra Therapeutics announces new pre-clinical data at 28th Annual Meeting of American Society of Gene and Cell Therapy (ASGCT)
unsupervised variability generation approach. Over 400,000 variants are tested using a proprietary high- throughput screening system grounded in synthetic biology principles. Our system compared favourably against existing systems like homology-directed repair (HDR) or homology-independent targeted insertion
More news about: Integra Therapeutics
May 07, 2025, 13:30 ET Israel's Mileutis Appoints Industry Leaders Dr. Joachim Hasenmaier and Mr. Aaron Schacht to Board of Directors
Aaron Schacht is the CEO of BiomEdit, Inc., a private biotech company backed by the Gates Foundation, which develops microbiome and synthetic biology innovations for animal health. Previously, he led R&D and Business Development at Elanco Animal Health, where he oversaw major acquisitions
More news about: Mileutis Ltd.
May 07, 2025, 11:02 ET GenoFAB Announces Publication of Groundbreaking Self-Documenting Plasmid Technology In Trends In Biotechnology
(970) 817-2400 x800, [email protected] About GenoFAB: GenoFAB is a synthetic biology platform dedicated to helping life scientists write and debug their ideas in DNA. With roots in academic research and a commitment to reproducibility,
More news about: GenoFAB
May 07, 2025, 08:00 ET Invaio Sciences, a Flagship Pioneering Company, Appoints Magalie Guilhabert as Chief Science Officer
overseeing a team of 100 scientists and technicians and managing a $41 million revenue target. Her leadership in synthetic biology, microbial genetics, and data science drove the development of a cutting-edge agricultural solutions portfolio, aligning scientific innovation
More news about: Invaio Sciences
May 06, 2025, 17:00 ET Ginkgo Bioworks Reports First Quarter 2025 Financial Results
business opportunities, including with respect to our solutions and tools offerings, (iv) the risk of downturns in demand for products using synthetic biology, (v) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (vi) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
May 05, 2025, 07:15 ET Atlas Data Storage Announces Initial Close of Seed Financing
extremely high data density, 1,000+ year durability, unlimited low-cost copies, and scalability. The company is spearheading the convergence of synthetic biology and information technology. Atlas' core technology combines novel semiconductor chips and enzyme engineering, ushering in a new era of high-throughput
More news about: Atlas Data Storage